Back to search

S Xpress Bio Limited

12216115

active
ltd
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH
Incorporated 19/09/2019

Previously known as

Hydrogen Therapeutics Limited · until 13/02/2025
Helium Tx Limited · until 28/04/2021

Compliance

Last accounts

31/10/2024

total exemption full

Next accounts due

31/07/2026

On track

Confirmation statement

Last: 18/09/2025

Due 02/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

The Cambridge Partnership Limited

secretary · Since 25/09/2019

Also on 34 other boards

Dr David John Grainger

director · Since 25/09/2019

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 59

Also on 12 other boards

Dr David Eder Mosedale

director · Since 12/02/2025

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 54

Also on 2 other boards

David John Grainger

director · Since 25/09/2019

British · England · Age 59

The Cambridge Partnership Limited

corporate secretary · Since 25/09/2019

Reg: 08288375

Also on 34 other boards

David Eder Mosedale

director · Since 12/02/2025

British · England · Age 54

Former

Victoria Jane Taylor

director · Resigned 12/02/2025

Persons with Significant Control

Elements Squared Limited

75–100% shares

C/O The Cambridge Partnership, The Dorothy Hodgkin Building, Cambridge

Reg: 12065441 · England And Wales · Limited Company

Notified 29/04/2020

Former PSCs

Dr David John Grainger

Ceased 29/04/2020

Change History

statusactive
2026-07-15

Active

typeltd
2026-07-15

Private Limited Company

address line1C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building
2026-07-15

C/O THE CAMBRIDGE PARTNERSHIP LTD, THE DOROTHY HODGKIN BUILDING

post townCambridge
2026-07-15

CAMBRIDGE

CompanyRankvs 1039+ SIC 72110 peers
62

Financial strength40th percentile among SIC peers · 10/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 15.56× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength10/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/10/2025

Net Worth

£100

Balance sheet strength

Cash

£19k

Cash in the bank

Net Current Assets

£33k

Working capital

Current Assets

£35k

Current Liabilities

£2k

Debtors

£16k

2avg. employees+2

Balance Sheet

Assets less current liabilities£33k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
202515.56
202455.76
202346.67

Derived from filed accounts. Not audited figures.